Cocrystal Pharma (COCP) News Today → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free COCP Stock Alerts $2.53 -0.05 (-1.94%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16, 2024 | finance.yahoo.comCOCP: Enrollment Complete in Phase 2a Human Challenge Trial of CC-42344…May 13, 2024 | investorplace.comCOCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024May 13, 2024 | globenewswire.comCocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMay 1, 2024 | finance.yahoo.comEnrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal InfluenzaMay 1, 2024 | globenewswire.comEnrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal InfluenzaApril 23, 2024 | finance.yahoo.comCOCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision Leads to Valuation of $6 Per Share…April 5, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and Icecure Medical (ICCM)March 28, 2024 | msn.comCOCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023March 28, 2024 | finanznachrichten.deCocrystal Pharma, Inc.: Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMarch 28, 2024 | benzinga.comRecap: Cocrystal Pharma Q4 EarningsMarch 28, 2024 | globenewswire.comCocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMarch 20, 2024 | finanznachrichten.deCocrystal Pharma, Inc.: Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza AMarch 19, 2024 | markets.businessinsider.comCocrystal Pharma Receives Pre-IND Feedback Regarding CC-42344 - Quick FactsMarch 19, 2024 | globenewswire.comCocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza AFebruary 24, 2024 | investing.comCocrystal Pharma Inc (COCP)February 20, 2024 | finance.yahoo.comCOCP: Cocrystal Pharma provides updates on its clinical programs.February 11, 2024 | morningstar.comCocrystal Pharma Inc COCPJanuary 4, 2024 | finance.yahoo.comCocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational CandidatesDecember 26, 2023 | benzinga.comCocrystal Pharma Stock (NASDAQ:COCP), Analyst Ratings, Price Targets, PredictionsDecember 26, 2023 | benzinga.comCocrystal Pharma Stock (NASDAQ:COCP) Dividends: History, Yield and DatesDecember 6, 2023 | finance.yahoo.comCocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza ANovember 29, 2023 | finance.yahoo.comCocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West CoastNovember 27, 2023 | finance.yahoo.comCocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023November 14, 2023 | benzinga.comCocrystal Pharma Stock (NASDAQ:COCP) Earnings Dates and Earning CallsNovember 14, 2023 | msn.comCOCP: Cocrystal Pharma reports 3rd quarter financial results and provides updates on clinical trials.November 13, 2023 | benzinga.comRecap: Cocrystal Pharma Q3 EarningsNovember 13, 2023 | finance.yahoo.comCocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development ProgramsNovember 9, 2023 | finance.yahoo.comCocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West CoastNovember 3, 2023 | markets.businessinsider.comBuy Rating Issued for Cocrystal Pharma Amid Advancements in Influenza and Coronavirus TreatmentsOctober 31, 2023 | finance.yahoo.comCocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344October 5, 2023 | msn.comHC Wainwright & Co. Reiterates Cocrystal Pharma (COCP) Buy RecommendationOctober 2, 2023 | finance.yahoo.comCOCP: Cocrystal Pharma doses 1st subjects in the important CDI-988 clinical trial.August 16, 2023 | finance.yahoo.comCOCP: Cocrystal Pharma reports 2nd quarter 2023 financial results and provides updates on drug pipeline.August 15, 2023 | markets.businessinsider.comAnalyst Ratings for Cocrystal PharmaAugust 15, 2023 | markets.businessinsider.comCocrystal Pharma (COCP) Receives a Buy from H.C. WainwrightAugust 15, 2023 | markets.businessinsider.comNoble Financial Keeps Their Buy Rating on Cocrystal Pharma (COCP)August 14, 2023 | finance.yahoo.comCocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development ProgramsAugust 11, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Tyra Bioscience (TYRA)August 8, 2023 | finance.yahoo.comCocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus LeadMay 31, 2023 | finance.yahoo.comCocrystal Pharma Receives HREC Approval to Initiate Phase 1 Study to Evaluate Oral Broad-Spectrum Coronavirus 3CL Protease Inhibitor CDI-988May 24, 2023 | msn.comHC Wainwright & Co. Maintains Cocrystal Pharma (COCP) Buy RecommendationMay 24, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Cocrystal Pharma (COCP)May 17, 2023 | finance.yahoo.comCOCP: Cocrystal Pharma reports 1st quarter 2023 financial results and provides updates on drug pipeline.May 15, 2023 | finance.yahoo.comCocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development ProgramsMay 4, 2023 | finance.yahoo.comCocrystal Pharma Presents New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group ConferenceApril 24, 2023 | finance.yahoo.comCocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of DirectorsApril 18, 2023 | finance.yahoo.comCocrystal Pharma to Present New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group ConferenceApril 12, 2023 | benzinga.comCocrystal Pharma Inc (COCP) Up 15.54% in Premarket TradingApril 10, 2023 | msn.comWhy Cocrystal Pharma Shares Are Trading Higher TodayApril 10, 2023 | finance.yahoo.comCocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight! TRY "INVESTING IDEAS" TODAY COCP Media Mentions By Week COCP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COCP News Sentiment▼1.000.76▲Average Medical News Sentiment COCP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COCP Articles This Week▼00▲COCP Articles Average Week Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ONCT News Today CLSD News Today VSTM News Today IFRX News Today PRPH News Today ETON News Today SCYX News Today ASRT News Today CNTB News Today HILS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COCP) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on...Paradigm Press | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored